世界の膜型人工肺の市場規模は2028年までに1億4,150万USドルに達する見込みです。この市場は、2021年から2028年にかけて、1.5%のCAGRで拡大すると予測されています。市場を後押しすると予想される主な要因には、呼吸不全や心肺疾患の有病率の増加が含まれます。さらに、COVID-19や慢性閉塞性肺疾患の患者数が増加しており、治療に膜型人工肺が必要になってきていることから、採用が進んでいます。医療機器の技術的進歩により、病院での需要がさらに高まることが予想されます。
この業界で活動する主要な市場企業は、技術的に高度な膜型人工肺の開発に注力しています。例えば、2019年1月、Terumo Medical Corporation社は、Ultraprime技術を搭載した最小のプライムボリューム、フルサイズの成人用人工肺であるCapiox NX19-を発売しました。この装置の大きな特徴は、炎症反応を最小限に抑え、より効率的に微小塞栓を除去できることです。また、重篤な患者の搬送に役立つECMO回路のポータブルアダプターやコンパクトな膜型人工肺も開発されています。最近の医療機器の開発は、市場の成長を促進すると推定されます。
心血管疾患は、世界中で主要な死因の一つとなっています。WHOによると、2016年には世界で約1,790万人のCVD（心血管疾患）関連死が報告されています。膜型人工肺は、心疾患や呼吸器疾患の患者の治療に使用されます。ECMO装置は、肺や心臓が血液の酸素化プロセスを実行できない場合に、患者の二酸化炭素を除去し、酸素を供給します。心疾患や呼吸器疾患の増加に伴い、この分野の成長が期待されています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. By Type
1.1.2. By Application
1.1.3. By Age group
1.1.4. Country scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. Age group outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Membrane Oxygenator Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of cardiopulmonary and respiratory diseases
3.4.1.2. Boosting adoption of membrane oxygenator
3.4.1.3. Technological advancements
3.4.1.4. Expanding applications
3.4.2. Market restraint analysis
3.4.2.1. Complications associated with membrane oxygenator treatment
3.4.2.2. Availability of conventional techniques
3.5. Membrane Oxygenator Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Membrane Oxygenator Market: By Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Hollow fiber membrane oxygenator
4.1.2. Flat sheet membrane oxygenators
4.2. Type Market Share, 2021 & 2028
4.3. Segment Dashboard
4.4. Global Membrane Oxygenator Market, by Type Outlook
4.4.1. Hollow fiber membrane oxygenators
4.4.1.1. Hollow fiber membrane oxygenators market estimates and forecast, 2016 - 2028 (USD Million)
4.4.2. Flat sheet membrane oxygenators
4.4.2.1. Flat sheet membrane oxygenators market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 5. Membrane Oxygenator Market: By Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Respiratory
5.1.2. Cardiac
5.1.3. ECPR
5.2. Application Market Share, 2021 & 2028
5.3. Segment Dashboard
5.4. Global Membrane Oxygenator Market, by Application Outlook
5.4.1. Respiratory
5.4.1.1. Respiratory market estimates and forecast, 2016 - 2028 (USD Million)
5.4.1.2. Respiratory failure
5.4.1.2.1. Respiratory failure market estimates and forecast, 2016 - 2028 (USD Million)
5.4.1.3. Pulmonary embolism
5.4.1.3.1. Pulmonary embolism market estimates and forecast, 2016 - 2028 (USD Million)
5.4.1.3.2. Acute respiratory distress syndrome
5.4.1.3.2.1. Acute respiratory distress syndrome market estimates and forecast, 2016 - 2028 (USD Million)
5.4.1.4. Pneumonia
5.4.1.4.1. Pneumonia market estimates and forecast, 2016 - 2028 (USD Million)
5.4.1.5. COVID-19
5.4.1.5.1. COVID-19 market estimates and forecast, 2016 - 2028 (USD Million)
5.4.2. Cardiac
5.4.2.1. Cardiac market estimates and forecast, 2016 - 2028 (USD Million)
5.4.2.2. Acute myocardial infarction
5.4.2.2.1. Acute myocardial infarction market estimates and forecast, 2016 - 2028 (USD Million)
5.4.2.3. Myocarditis
5.4.2.3.1. Myocarditis market estimates and forecast, 2016 - 2028 (USD Million)
5.4.2.4. Post-transplant complications
5.4.2.4.1. Post-transplant complications market estimates and forecast, 2016 - 2028 (USD Million)
5.4.2.5. Decompensated cardiomyopathy
5.4.2.5.1. Decompensated cardiomyopathy market estimates and forecast, 2016 - 2028 (USD Million)
5.4.2.6. Cardiogenic shock
5.4.2.6.1. Cardiogenic shock market estimates and forecast, 2016 - 2028 (USD Million)
5.4.3. ECPR
5.4.3.1. ECPR market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 6. Membrane Oxygenator Market: By Age group Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Adults
6.1.2. Neonates
6.1.3. Pediatrics
6.2. By Age group Market Share, 2021 & 2028
6.3. Segment Dashboard
6.4. Global Membrane Oxygenator Market by Age group Outlook
6.4.1. Adults
6.4.1.1. Adults market estimates and forecast, 2016 - 2028 (USD Million)
6.4.2. Neonates
6.4.2.1. Neonates market estimates and forecast, 2016 - 2028 (USD Million)
6.4.3. Pediatrics
6.4.3.1. Pediatrics market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 7. Membrane Oxygenator Market: Country Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2021 & 2028
7.2. County Market Dashboard
7.3. Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2028:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.7.2. U.S.
7.7.2.1. U.S. market estimates and forecast, 2016 - 2028 (USD Million)
7.7.3. Canada
7.7.3.1. Canada market estimates and forecast, 2016 - 2028 (USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.2. U.K.
7.8.2.1. U.K. market estimates and forecast, 2016 - 2028 (USD Million)
7.8.3. Germany
7.8.3.1. Germany market estimates and forecast, 2016 - 2028 (USD Million)
7.8.4. France
7.8.4.1. France market estimates and forecast, 2016 - 2028 (USD Million)
7.8.5. Italy
7.8.5.1. Italy market estimates and forecast, 2016 - 2028 (USD Million)
7.8.6. Spain
7.8.6.1. Spain market estimates and forecast, 2016 - 2028 (USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.2. Japan
7.9.2.1. Japan market estimates and forecast, 2016 - 2028 (USD Million)
7.9.3. China
7.9.3.1. China market estimates and forecast, 2016 - 2028 (USD Million)
7.9.4. India
7.9.4.1. India market estimates and forecast, 2016 - 2028 (USD Million)
7.9.5. South Korea
7.9.5.1. South Korea market estimates and forecast, 2016 - 2028 (USD Million)
7.9.6. Australia
7.9.6.1. Australia market estimates and forecast, 2016 - 2028 (USD Million)
7.9.7. Thailand
7.9.7.1. Thailand market estimates and forecast, 2016 - 2028 (USD Million)
7.10. Latin America
7.10.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.10.2. Brazil
7.10.2.1. Brazil market estimates and forecast, 2016 - 2028 (USD Million)
7.10.3. Mexico
7.10.3.1. Mexico market estimates and forecast, 2016 - 2028 (USD Million)
7.10.4. Argentina
7.10.4.1. Argentina market estimates and forecast, 2016 - 2028 (USD Million)
7.10.5. Colombia
7.10.5.1. Colombia market estimates and forecast, 2016 - 2028 (USD Million)
7.11. Middle East & Africa
7.11.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11.2. South Africa
7.11.2.1. South Africa market estimates and forecast, 2016 - 2028 (USD Million)
7.11.3. Saudi Arabia
7.11.3.1. Saudi Arabia market estimates and forecast, 2016 - 2028 (USD Million)
7.11.4. UAE
7.11.4.1. UAE market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2020
8.3.4. Medtronic
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Type benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Fresenius SE & Co KGaA
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Type benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Getinge AB
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Type benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Terumo Medical Corporation
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Type benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Microport Scientific Corporation
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Type benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Nipro Medical Corporation
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Type benchmarking
8.3.9.4. Strategic initiatives
8.3.10. LivaNova PLC
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Type benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Cytosorbents Corporation
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Type benchmarking
8.3.11.4. Strategic initiatives
